Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,298 | -5,352 | -20,988 | -14,739 | -11,139 |
| Depreciation Amortization | 153 | 77 | 361 | 282 | 220 |
| Other Working Capital | -1,773 | -519 | -725 | -616 | -1,630 |
| Other Operating Activity | 605 | 857 | 3,452 | 2,284 | 2,480 |
| Operating Cash Flow | $-10,313 | $-4,937 | $-17,900 | $-12,789 | $-10,068 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -28 | -228 | -168 | -5 |
| Investing Cash Flow | $-37 | $-28 | $-228 | $-168 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 184 | 184 | 188 |
| Other Financing Activity | 4,049 | 3,959 | 26,159 | 26,085 | 26,800 |
| Financing Cash Flow | $4,049 | $3,959 | $26,343 | $26,269 | $26,988 |
| Exchange Rate Effect | 371 | -399 | -202 | 87 | -973 |
| Beginning Cash Position | 32,312 | 32,581 | 24,910 | 24,801 | 25,419 |
| End Cash Position | 26,382 | 31,176 | 32,923 | 38,201 | 41,361 |
| Net Cash Flow | $-5,930 | $-1,405 | $8,013 | $13,400 | $15,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,313 | -4,937 | -17,900 | -12,789 | -10,068 |
| Capital Expenditure | -37 | -28 | -228 | -168 | -5 |
| Free Cash Flow | -10,350 | -4,965 | -18,128 | -12,956 | -10,073 |